298.55
price down icon1.43%   -4.33
 
loading
Medpace Holdings Inc stock is traded at $298.55, with a volume of 399.58K. It is down -1.43% in the last 24 hours and down -8.00% over the past month. Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
See More
Previous Close:
$302.88
Open:
$300
24h Volume:
399.58K
Relative Volume:
0.87
Market Cap:
$8.31B
Revenue:
$2.07B
Net Income/Loss:
$365.67M
P/E Ratio:
26.14
EPS:
11.42
Net Cash Flow:
$535.65M
1W Performance:
+0.77%
1M Performance:
-8.00%
6M Performance:
-9.59%
1Y Performance:
-23.40%
1-Day Range:
Value
$291.55
$300.00
1-Week Range:
Value
$250.05
$303.78
52-Week Range:
Value
$250.05
$459.77

Medpace Holdings Inc Stock (MEDP) Company Profile

Name
Name
Medpace Holdings Inc
Name
Phone
(513) 579-9911
Name
Address
5375 MEDPACE WAY, CINCINNATI, OH
Name
Employee
5,900
Name
Twitter
@WorkatMedpace
Name
Next Earnings Date
2025-04-21
Name
Latest SEC Filings
Name
MEDP's Discussions on Twitter

Compare MEDP with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
MEDP
Medpace Holdings Inc
298.55 8.31B 2.07B 365.67M 535.65M 11.42
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
424.24 159.25B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
197.14 132.37B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
437.44 32.95B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
A
Agilent Technologies Inc
106.28 28.58B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
150.28 24.90B 15.41B 1.37B 2.11B 7.50

Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-22-25 Downgrade William Blair Outperform → Mkt Perform
Apr-14-25 Downgrade TD Cowen Buy → Hold
Mar-24-25 Initiated Leerink Partners Market Perform
Oct-23-24 Downgrade Robert W. Baird Outperform → Neutral
Oct-14-24 Initiated Redburn Atlantic Buy
Sep-27-24 Downgrade UBS Buy → Neutral
Sep-25-24 Downgrade Jefferies Buy → Hold
Aug-01-24 Initiated Truist Hold
May-29-24 Initiated TD Cowen Buy
May-28-24 Initiated Mizuho Buy
Apr-23-24 Upgrade Jefferies Hold → Buy
Mar-18-24 Initiated Deutsche Bank Hold
Feb-15-24 Upgrade UBS Neutral → Buy
Oct-24-23 Upgrade Robert W. Baird Neutral → Outperform
May-08-23 Upgrade Guggenheim Neutral → Buy
Oct-27-22 Upgrade UBS Sell → Neutral
Sep-07-22 Initiated UBS Sell
May-24-22 Initiated Guggenheim Neutral
Aug-05-21 Resumed Credit Suisse Outperform
Oct-02-20 Upgrade Truist Hold → Buy
Jun-08-20 Upgrade Robert W. Baird Underperform → Neutral
May-13-20 Downgrade Wolfe Research Outperform → Peer Perform
Apr-30-20 Upgrade SunTrust Sell → Hold
Apr-20-20 Downgrade Robert W. Baird Neutral → Underperform
Mar-17-20 Downgrade SunTrust Hold → Sell
Jan-27-20 Downgrade SunTrust Buy → Hold
Oct-31-18 Upgrade SunTrust Hold → Buy
Sep-17-18 Initiated SunTrust Hold
Jul-31-18 Upgrade William Blair Mkt Perform → Outperform
Nov-01-17 Downgrade William Blair Outperform → Mkt Perform
Sep-29-17 Initiated Raymond James Mkt Perform
Jul-10-17 Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
View All

Medpace Holdings Inc Stock (MEDP) Latest News

pulisher
12:01 PM

Medpace (MEDP) Faces Earnings Volatility Amid Tariff Concerns - GuruFocus

12:01 PM
pulisher
Apr 26, 2025

Medpace drops despite Q1 beat amid disappointing performance metrics - MSN

Apr 26, 2025
pulisher
Apr 26, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 25, 2025

Medpace forecasts 2025 revenue between $2.14B and $2.24B amid funding challenges - MSN

Apr 25, 2025
pulisher
Apr 25, 2025

Decoding Medpace Holdings Inc (MEDP): A Strategic SWOT Insight - GuruFocus

Apr 25, 2025
pulisher
Apr 24, 2025

Medpace to increase size of stock buyback program by $1B - MSN

Apr 24, 2025
pulisher
Apr 23, 2025

William Blair Downgrades Medpace Holdings (BMV:MEDP) - Nasdaq

Apr 23, 2025
pulisher
Apr 23, 2025

Truist Adjusts Medpace (MEDP) Price Target to $300, Maintains Hold Rating | MEDP Stock News - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Medpace Holdings, Inc. (NASDAQ:MEDP) Q1 2025 Earnings Call Transcript - Insider Monkey

Apr 23, 2025
pulisher
Apr 23, 2025

Medpace (MEDP) Price Target Reduced to $313 Amid Cautious Outlook | MEDP Stock News - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Medpace Holdings First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Apr 23, 2025
pulisher
Apr 23, 2025

Medpace Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - simplywall.st

Apr 23, 2025
pulisher
Apr 23, 2025

Medpace Holdings Inc (MEDP) Q1 2025 Earnings Call Highlights: Revenue Growth Amidst Competitive ... - Yahoo Finance

Apr 23, 2025
pulisher
Apr 23, 2025

Medpace Holdings Inc (MEDP) Q1 2025 Earnings Call Highlights: Revenue Growth Amidst Competitive Challenges - GuruFocus

Apr 23, 2025
pulisher
Apr 22, 2025

Medpace Holdings Reports Strong Q1 2025 Results - TipRanks

Apr 22, 2025
pulisher
Apr 22, 2025

Medpace Holdings Inc. Earnings Call: Mixed Sentiments and Modest Growth - TipRanks

Apr 22, 2025
pulisher
Apr 22, 2025

Medpace Holdings Stock Falls 11.2% Post Q1 2025 EarningsNews and Statistics - IndexBox

Apr 22, 2025
pulisher
Apr 22, 2025

Medpace Holdings, Inc. SEC 10-Q Report - TradingView

Apr 22, 2025
pulisher
Apr 22, 2025

Medpace (MEDP) Reports Revenue Growth Despite Challenges - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

Medpace (MEDP) Stock Declines on Earnings Report - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

Medpace (MEDP) Expands Share Buyback Program by $1 Billion - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

Medpace Holdings, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:MEDP) - Seeking Alpha

Apr 22, 2025
pulisher
Apr 22, 2025

Why Medpace (MEDP) Stock Is Trading Lower Today - Yahoo Finance

Apr 22, 2025
pulisher
Apr 22, 2025

Medpace stock rating cut to Market Perform by William Blair - Investing.com South Africa

Apr 22, 2025
pulisher
Apr 22, 2025

Medpace (MEDP) Disappoints with Key Metrics Despite Strong Financials - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

Medpace stock drops despite Q1 beat (MEDP:NASDAQ) - Seeking Alpha

Apr 22, 2025
pulisher
Apr 22, 2025

TD Cowen holds Medpace stock rating, maintains $328 target - Investing.com

Apr 22, 2025
pulisher
Apr 22, 2025

Medpace Hits 17-Month Low After Bookings Miss Leaves Investors Mystified - MSN

Apr 22, 2025
pulisher
Apr 22, 2025

Medpace (MEDP) Exceeds Q1 Earnings Expectations - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

Medpace (MEDP) Surpasses Revenue and EPS Expectations in Q1 2025 - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

TD Cowen holds Medpace stock rating, maintains $328 target By Investing.com - Investing.com Canada

Apr 22, 2025
pulisher
Apr 22, 2025

Earnings call transcript: Medpace Q1 2025 beats forecasts, shares drop - Investing.com

Apr 22, 2025
pulisher
Apr 22, 2025

Earnings call transcript: Medpace Q1 2025 beats forecasts, shares drop By Investing.com - Investing.com UK

Apr 22, 2025
pulisher
Apr 22, 2025

S&P 500 Futures Climb in Premarket Trading; Northrop Grumman, Medpace Holdings Lag - Barron's

Apr 22, 2025
pulisher
Apr 22, 2025

Medpace: Q1 Earnings Snapshot - MySA

Apr 22, 2025
pulisher
Apr 22, 2025

Medpace Holdings’ revenue increases 9.3% to USD 558.6M in Q1 2025 - Medical Buyer

Apr 22, 2025
pulisher
Apr 21, 2025

Medpace Holdings earnings beat by $0.62, revenue topped estimates - Investing.com Canada

Apr 21, 2025
pulisher
Apr 21, 2025

Medpace Holdings Stock Dips Amid Market Challenges - TipRanks

Apr 21, 2025
pulisher
Apr 21, 2025

Medpace (MEDP) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance

Apr 21, 2025
pulisher
Apr 21, 2025

Medpace Holdings Reports Q1 Earnings, Shares Move Lower - Benzinga

Apr 21, 2025
pulisher
Apr 21, 2025

Medpace Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView

Apr 21, 2025
pulisher
Apr 21, 2025

Medpace (MEDP) Exceeds Q1 Expectations, Projects 2025 Growth - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Medpace Holdings Exceeds Q1 Revenue Forecasts and Adjusts Full-Year OutlookNews and Statistics - IndexBox

Apr 21, 2025
pulisher
Apr 21, 2025

Medpace Q1 Earnings, Revenue Rise; Issues Guidance - marketscreener.com

Apr 21, 2025
pulisher
Apr 21, 2025

Medpace shares fall as Q2 bookings miss expectations - Investing.com Australia

Apr 21, 2025
pulisher
Apr 21, 2025

Medpace shares fall as Q2 bookings miss expectations By Investing.com - Investing.com India

Apr 21, 2025
pulisher
Apr 21, 2025

Medpace Holdings, Inc. Reports First Quarter 2025 Results | MEDP Stock News - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Medpace Holdings Inc Surpasses Q1 2025 Estimates with $3.67 EPS and $558.6 Million Revenue - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Medpace (NASDAQ:MEDP) Beats Expectations in Strong Q1 But Stock Drops - Yahoo Finance

Apr 21, 2025
pulisher
Apr 21, 2025

Medpace (NASDAQ:MEDP) Beats Expectations In Strong Q1 But Stock Drops - Barchart.com

Apr 21, 2025
pulisher
Apr 21, 2025

Earnings Flash (MEDP) Medpace Holdings Reports Q1 Revenue $558.6M, vs. FactSet Est of $526.3M - marketscreener.com

Apr 21, 2025

Medpace Holdings Inc Stock (MEDP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Medpace Holdings Inc Stock (MEDP) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Troendle August J.
CEO
Mar 07 '25
Option Exercise
68.62
356,446
24,458,835
1,011,102
EWALD STEPHEN P
General Counsel & Corp. Secy.
Feb 27 '25
Buy
326.11
2
652
13,343
Carley Brian T
Director
Feb 24 '25
Option Exercise
42.62
8,127
346,373
30,035
Carley Brian T
Director
Feb 24 '25
Sale
345.59
4,003
1,383,397
26,032
diagnostics_research LH
$228.31
price down icon 0.12%
diagnostics_research DGX
$173.76
price down icon 1.20%
$153.79
price down icon 0.45%
diagnostics_research WAT
$337.89
price down icon 0.82%
diagnostics_research MTD
$1,061.79
price down icon 1.23%
diagnostics_research IQV
$150.28
price down icon 0.27%
Cap:     |  Volume (24h):